TI
PTCT icon

Tidal Investments’s PTC Therapeutics PTCT Stock Holding History

Tidal Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+2,589
New +$187K ﹤0.01% 2435
2026
Q1 		– Sell
-14,380
Closed -$1.09M – 2532
2025
Q4 		$1.09M Sell
14,380
-1,313
-8% -$95.4K ﹤0.01% 1222
2025
Q3 		$963K Buy
15,693
+1,298
+9% +$67.6K ﹤0.01% 1236
2025
Q2 		$703K Buy
+14,395
New +$683K ﹤0.01% 1194

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Tidal Investments's PTCT Position: Q2 2026 in Review

Tidal Investments opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 2,589 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings. This is a return to the name: Tidal Investments previously reported a position in PTCT as recently as Q4 2025.

Tidal Investments first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.09M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Tidal Investments held 2,589 shares of PTC Therapeutics worth $211K as of Q2 2026.
  • PTC Therapeutics was a new Tidal Investments position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2435 holding.
  • Tidal Investments first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Tidal Investments's PTC Therapeutics position peaked at $1.09M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.